In an early clinical trial, an experimental norovirus vaccine given as a pill produced defensive responses exactly where it ...

The vaccine used mRNA technology, which is where genetic instructions are used to trigger an immune response in the body, as opposed to using a weakened or deadened version of a virus.

The new vaccine addresses significant limitations of existing COVID-19 and flu vaccines. While mRNA COVID-19 vaccines require ultra-cold storage and flu vaccines often offer less than 50% efficacy ...

A study has established the importance of immunoglobulin A, an antibody that is part of the immune system, in generating a response to pneumonia vaccines. Researchers have found that the absence of ...

New research suggests that receiving multiple doses of a vaccine in the same limb leads to faster antibody development, an ...

During the first address to Congress of his second term this week, President Donald Trump bragged about the accomplishments ...

Another, which received $455,000, uses mice to study how hormone therapy may impact someone's immune response to an HIV vaccine. A $299,940 study examines how gender-affirming hormone therapy impacts ...

This study explores the potential of oncomicrobial vaccines in mitigating tumor progression by targeting specific ...

Gut microbiota may be the key factor explaining why certain individuals do not respond well to the pneumococcal vaccine-a bacterium that can cause ...

Cornell researchers have developed a stable, multi-target vaccine offering long-lasting protection against COVID-19 and influenza, with promising results in mice. Cornell University researchers have ...